FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904110894> ?p ?o ?g. }

• W2904110894 abstract "To identify factors influencing return for maintenance percutaneous tibial nerve stimulation (PTNS) treatment after successful completion of a 12-week course of treatment for overactive bladder (OAB).Patients with OAB symptoms referred for PTNS treatment underwent 12 sessions of weekly PTNS treatment and were evaluated at baseline and week 12 using the International Consultation on Incontinence Questionnaire on OAB, the International Consultation on Incontinence Questionnaire on lower urinary tract symptom-related quality of life (ICIQ-LUTSqol) and a bladder diary (BD). Responders to treatment, evaluated using two patient-reported outcome measures, were invited to return for maintenance treatment when symptoms returned. A PTNS Service Evaluation Questionnaire was used to evaluate factors influencing return for maintenance treatment.Seventy-three patients were evaluated (mean age 58.9 [±14.7] years, 72.6% women) and clustered into three groups: group 1 (n = 25) did not respond to 12 weekly sessions of PTNS treatment; group 2 (n = 17) responded to treatment but did not return for maintenance treatment and group 3 (n = 31) responded to treatment and returned for maintenance treatment. There were no significant differences in demographic characteristics, diagnosis, baseline symptom scores and BD variables among the three groups. Patients belonging to groups 2 and 3 experienced a significant improvement from baseline to week 12 in total OAB scores (group 2: -1.54 ± 1.85; group 3: -1.85 ± 2.28; P < 0.05); however, patients returning for maintenance treatment reported significant improvements specifically in nocturia (BD difference = -0.4 ± 0.7 [P < 0.05] and ICIQ-LUTSqol difference -0.48 ± 0.94 [P < 0.05]), and perceived benefits of the treatment with regard to their OAB symptoms compared to those not returning for maintenance treatment (difference between the two groups 25.6%; P = 0.030). Improvements in nocturia and perceived benefits predicted return for maintenance treatment based on a logistic regression analysis. Factors related to the need for repeat clinic visits, such as transportation, distance and time commitment, were not found to differ between the two groups.Twelve-session weekly PTNS is a safe and effective treatment for OAB. Responders to treatment returning for maintenance PTNS more often reported significant improvements in nocturia and perceived benefits over time, compared to those not returning for maintenance treatment. The BD provides a more objective assessment of treatment outcome after PTNS treatment." @default.
• W2904110894 created "2018-12-22" @default.
• W2904110894 creator A5011125496 @default.
• W2904110894 creator A5013338944 @default.
• W2904110894 creator A5016796989 @default.
• W2904110894 creator A5033272212 @default.
• W2904110894 creator A5035157697 @default.
• W2904110894 creator A5055680663 @default.
• W2904110894 creator A5065966214 @default.
• W2904110894 creator A5073026824 @default.
• W2904110894 date "2019-02-03" @default.
• W2904110894 modified "2023-10-16" @default.
• W2904110894 title "Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder" @default.
• W2904110894 cites W1869342959 @default.
• W2904110894 cites W1925817549 @default.
• W2904110894 cites W1965240443 @default.
• W2904110894 cites W1972477468 @default.
• W2904110894 cites W1978127690 @default.
• W2904110894 cites W1993252258 @default.
• W2904110894 cites W2000095279 @default.
• W2904110894 cites W2009244027 @default.
• W2904110894 cites W2023060952 @default.
• W2904110894 cites W2023110392 @default.
• W2904110894 cites W2024863897 @default.
• W2904110894 cites W2027340686 @default.
• W2904110894 cites W2029525798 @default.
• W2904110894 cites W2035491712 @default.
• W2904110894 cites W2047813421 @default.
• W2904110894 cites W2049460340 @default.
• W2904110894 cites W2054335681 @default.
• W2904110894 cites W2067889220 @default.
• W2904110894 cites W2072032461 @default.
• W2904110894 cites W2085026637 @default.
• W2904110894 cites W2105588889 @default.
• W2904110894 cites W2113247433 @default.
• W2904110894 cites W2123162799 @default.
• W2904110894 cites W2125983326 @default.
• W2904110894 cites W2130637800 @default.
• W2904110894 cites W2132279199 @default.
• W2904110894 cites W2154268224 @default.
• W2904110894 cites W2155999507 @default.
• W2904110894 cites W2157359813 @default.
• W2904110894 cites W2168499550 @default.
• W2904110894 cites W2171353230 @default.
• W2904110894 cites W2309396695 @default.
• W2904110894 cites W2768379785 @default.
• W2904110894 doi "https://doi.org/10.1111/bju.14651" @default.
• W2904110894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30552801" @default.
• W2904110894 hasPublicationYear "2019" @default.
• W2904110894 type Work @default.
• W2904110894 sameAs 2904110894 @default.
• W2904110894 citedByCount "13" @default.
• W2904110894 countsByYear W29041108942019 @default.
• W2904110894 countsByYear W29041108942020 @default.
• W2904110894 countsByYear W29041108942021 @default.
• W2904110894 countsByYear W29041108942022 @default.
• W2904110894 countsByYear W29041108942023 @default.
• W2904110894 crossrefType "journal-article" @default.
• W2904110894 hasAuthorship W2904110894A5011125496 @default.
• W2904110894 hasAuthorship W2904110894A5013338944 @default.
• W2904110894 hasAuthorship W2904110894A5016796989 @default.
• W2904110894 hasAuthorship W2904110894A5033272212 @default.
• W2904110894 hasAuthorship W2904110894A5035157697 @default.
• W2904110894 hasAuthorship W2904110894A5055680663 @default.
• W2904110894 hasAuthorship W2904110894A5065966214 @default.
• W2904110894 hasAuthorship W2904110894A5073026824 @default.
• W2904110894 hasBestOaLocation W29041108942 @default.
• W2904110894 hasConcept C126322002 @default.
• W2904110894 hasConcept C126894567 @default.
• W2904110894 hasConcept C142724271 @default.
• W2904110894 hasConcept C159110408 @default.
• W2904110894 hasConcept C1862650 @default.
• W2904110894 hasConcept C204787440 @default.
• W2904110894 hasConcept C2777333188 @default.
• W2904110894 hasConcept C2778941218 @default.
• W2904110894 hasConcept C2779951463 @default.
• W2904110894 hasConcept C71924100 @default.
• W2904110894 hasConcept C77411442 @default.
• W2904110894 hasConceptScore W2904110894C126322002 @default.
• W2904110894 hasConceptScore W2904110894C126894567 @default.
• W2904110894 hasConceptScore W2904110894C142724271 @default.
• W2904110894 hasConceptScore W2904110894C159110408 @default.
• W2904110894 hasConceptScore W2904110894C1862650 @default.
• W2904110894 hasConceptScore W2904110894C204787440 @default.
• W2904110894 hasConceptScore W2904110894C2777333188 @default.
• W2904110894 hasConceptScore W2904110894C2778941218 @default.
• W2904110894 hasConceptScore W2904110894C2779951463 @default.
• W2904110894 hasConceptScore W2904110894C71924100 @default.
• W2904110894 hasConceptScore W2904110894C77411442 @default.
• W2904110894 hasFunder F4320320286 @default.
• W2904110894 hasFunder F4320320924 @default.
• W2904110894 hasIssue "5A" @default.
• W2904110894 hasLocation W29041108941 @default.
• W2904110894 hasLocation W29041108942 @default.
• W2904110894 hasLocation W29041108943 @default.
• W2904110894 hasLocation W29041108944 @default.
• W2904110894 hasLocation W29041108945 @default.
• W2904110894 hasOpenAccess W2904110894 @default.
• W2904110894 hasPrimaryLocation W29041108941 @default.
• W2904110894 hasRelatedWork W1996534025 @default.

• next